메뉴 건너뛰기




Volumn 42, Issue 12, 2012, Pages 1287-1294

Effects of ezetimibe on visceral fat in the metabolic syndrome: A randomised controlled study

Author keywords

Adiponectin; Hepatic steatosis; Hyperlipidaemia; Insulin resistance; Lipid; Obesity

Indexed keywords

ADIPONECTIN; EZETIMIBE; INSULIN;

EID: 84869889959     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12000     Document Type: Article
Times cited : (47)

References (34)
  • 1
    • 4644279733 scopus 로고    scopus 로고
    • Increasing prevalence of the metabolic syndrome among U.S. adults
    • Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004;27:2444-9.
    • (2004) Diabetes Care , vol.27 , pp. 2444-2449
    • Ford, E.S.1    Giles, W.H.2    Mokdad, A.H.3
  • 2
    • 2442647863 scopus 로고    scopus 로고
    • Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women
    • Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004;164:1066-76.
    • (2004) Arch Intern Med , vol.164 , pp. 1066-1076
    • Hu, G.1    Qiao, Q.2    Tuomilehto, J.3    Balkau, B.4    Borch-Johnsen, K.5    Pyorala, K.6
  • 3
    • 33846048384 scopus 로고    scopus 로고
    • Relationship between metabolic syndrome and Trp64Arg polymorphism of the β3-adrenergic receptor gene in a general sample: the Shigaraki study
    • Tamaki S, Nakamura Y, Tabara Y, Okamura T, Kita Y, Kadowaki T et al. Relationship between metabolic syndrome and Trp64Arg polymorphism of the β3-adrenergic receptor gene in a general sample: the Shigaraki study. Hypertens Res 2006;29:891-6.
    • (2006) Hypertens Res , vol.29 , pp. 891-896
    • Tamaki, S.1    Nakamura, Y.2    Tabara, Y.3    Okamura, T.4    Kita, Y.5    Kadowaki, T.6
  • 4
    • 33847630752 scopus 로고    scopus 로고
    • Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis
    • Mancia G, Bombelli M, Corrao G, Facchetti R, Madotto F, Giannattasio C et al. Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis. Hypertension 2007;49:40-7.
    • (2007) Hypertension , vol.49 , pp. 40-47
    • Mancia, G.1    Bombelli, M.2    Corrao, G.3    Facchetti, R.4    Madotto, F.5    Giannattasio, C.6
  • 5
    • 21544462572 scopus 로고    scopus 로고
    • Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence
    • Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005;28:1769-78.
    • (2005) Diabetes Care , vol.28 , pp. 1769-1778
    • Ford, E.S.1
  • 6
    • 33748776056 scopus 로고    scopus 로고
    • Metabolic syndrome and risk of cardiovascular disease: a meta-analysis
    • Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006;119:812-9.
    • (2006) Am J Med , vol.119 , pp. 812-819
    • Galassi, A.1    Reynolds, K.2    He, J.3
  • 7
    • 20444461614 scopus 로고    scopus 로고
    • Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men-the Tanno and Sobetsu Study
    • Takeuchi H, Saitoh S, Takagi S, Ohnishi H, Ohhata J, Isobe T et al. Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men-the Tanno and Sobetsu Study. Hypertens Res 2005;28:203-8.
    • (2005) Hypertens Res , vol.28 , pp. 203-208
    • Takeuchi, H.1    Saitoh, S.2    Takagi, S.3    Ohnishi, H.4    Ohhata, J.5    Isobe, T.6
  • 8
    • 34247266656 scopus 로고    scopus 로고
    • Relationship between arterial stiffness and the risk of coronary artery disease in subjects with and without metabolic syndrome
    • Koji Y, Tomiyama H, Yamada J, Yambe M, Motobe K, Shiina K et al. Relationship between arterial stiffness and the risk of coronary artery disease in subjects with and without metabolic syndrome. Hypertens Res 2007;30:243-7.
    • (2007) Hypertens Res , vol.30 , pp. 243-247
    • Koji, Y.1    Tomiyama, H.2    Yamada, J.3    Yambe, M.4    Motobe, K.5    Shiina, K.6
  • 9
    • 0038324573 scopus 로고    scopus 로고
    • Relationship among systolic blood pressure, serum insulin and leptin, and visceral fat accumulation in obese children
    • Nishina M, Kikuchi T, Yamazaki H, Kameda K, Hiura M, Uchiyama M. Relationship among systolic blood pressure, serum insulin and leptin, and visceral fat accumulation in obese children. Hypertens Res 2003;26:281-8.
    • (2003) Hypertens Res , vol.26 , pp. 281-288
    • Nishina, M.1    Kikuchi, T.2    Yamazaki, H.3    Kameda, K.4    Hiura, M.5    Uchiyama, M.6
  • 10
    • 17844385849 scopus 로고    scopus 로고
    • Usefulness of serum adiponectin level as a diagnostic marker of metabolic syndrome in obese Japanese children
    • Ogawa Y, Kikuchi T, Nagasaki K, Hiura M, Tanaka Y, Uchiyama M. Usefulness of serum adiponectin level as a diagnostic marker of metabolic syndrome in obese Japanese children. Hypertens Res 2005;28:51-7.
    • (2005) Hypertens Res , vol.28 , pp. 51-57
    • Ogawa, Y.1    Kikuchi, T.2    Nagasaki, K.3    Hiura, M.4    Tanaka, Y.5    Uchiyama, M.6
  • 11
    • 33646572904 scopus 로고    scopus 로고
    • The metabolic syndrome and adipocytokines
    • Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett 2006;580:2917-21.
    • (2006) FEBS Lett , vol.580 , pp. 2917-2921
    • Matsuzawa, Y.1
  • 12
    • 33745834319 scopus 로고    scopus 로고
    • Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
    • Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006;116:1784-92.
    • (2006) J Clin Invest , vol.116 , pp. 1784-1792
    • Kadowaki, T.1    Yamauchi, T.2    Kubota, N.3    Hara, K.4    Ueki, K.5    Tobe, K.6
  • 13
    • 34247218635 scopus 로고    scopus 로고
    • Relationship between visceral fat and cardiovascular disease risk factors: the Tanno and Sobetsu study
    • Chiba Y, Saitoh S, Takagi S, Ohnishi H, Katoh N, Ohata J et al. Relationship between visceral fat and cardiovascular disease risk factors: the Tanno and Sobetsu study. Hypertens Res 2007;30:229-36.
    • (2007) Hypertens Res , vol.30 , pp. 229-236
    • Chiba, Y.1    Saitoh, S.2    Takagi, S.3    Ohnishi, H.4    Katoh, N.5    Ohata, J.6
  • 14
    • 34249003668 scopus 로고    scopus 로고
    • Visceral obesity in Japanese patients with metabolic syndrome: reappraisal of diagnostic criteria by CT scan
    • Eguchi M, Tsuchihashi K, Saitoh S, Odawara Y, Hirano T, Nakata T et al. Visceral obesity in Japanese patients with metabolic syndrome: reappraisal of diagnostic criteria by CT scan. Hypertens Res 2007;30:315-23.
    • (2007) Hypertens Res , vol.30 , pp. 315-323
    • Eguchi, M.1    Tsuchihashi, K.2    Saitoh, S.3    Odawara, Y.4    Hirano, T.5    Nakata, T.6
  • 16
    • 10744221008 scopus 로고    scopus 로고
    • Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption
    • Altmann SW, Davis HR Jr, Zhu LJ, Yao X, Hoos LM, Tetzloff G et al. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 2004;303:1201-4.
    • (2004) Science , vol.303 , pp. 1201-1204
    • Altmann, S.W.1    Davis Jr., H.R.2    Zhu, L.J.3    Yao, X.4    Hoos, L.M.5    Tetzloff, G.6
  • 18
    • 67650552637 scopus 로고    scopus 로고
    • Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia
    • Tremblay AJ, Lamarche B, Hogue JC, Couture P. Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia. J Lipid Res 2009;50:1463-71.
    • (2009) J Lipid Res , vol.50 , pp. 1463-1471
    • Tremblay, A.J.1    Lamarche, B.2    Hogue, J.C.3    Couture, P.4
  • 20
    • 77952674608 scopus 로고    scopus 로고
    • Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet
    • Chan DC, Watts GF, Gan SK, Ooi EM, Barrett PH. Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet. Diabetes Care 2010;33:1134-9.
    • (2010) Diabetes Care , vol.33 , pp. 1134-1139
    • Chan, D.C.1    Watts, G.F.2    Gan, S.K.3    Ooi, E.M.4    Barrett, P.H.5
  • 21
    • 76249107102 scopus 로고    scopus 로고
    • The effects of ezetimibe on surrogate markers of cholesterol absorption and synthesis in Japanese patients with dyslipidemia
    • Hiramitsu S, Ishiguro Y, Matsuyama H, Yamada K, Kato K, Noba M et al. The effects of ezetimibe on surrogate markers of cholesterol absorption and synthesis in Japanese patients with dyslipidemia. J Atheroscler Thromb 2010;17:106-14.
    • (2010) J Atheroscler Thromb , vol.17 , pp. 106-114
    • Hiramitsu, S.1    Ishiguro, Y.2    Matsuyama, H.3    Yamada, K.4    Kato, K.5    Noba, M.6
  • 22
    • 78651473467 scopus 로고    scopus 로고
    • Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
    • Park H, Shima T, Yamaguchi K, Mitsuyoshi H, Minami M, Yasui K et al. Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease. J Gastroenterol 2011;46:101-7.
    • (2011) J Gastroenterol , vol.46 , pp. 101-107
    • Park, H.1    Shima, T.2    Yamaguchi, K.3    Mitsuyoshi, H.4    Minami, M.5    Yasui, K.6
  • 23
    • 36549013633 scopus 로고    scopus 로고
    • Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome
    • Deushi M, Nomura M, Kawakami A, Haraguchi M, Ito M, Okazaki M et al. Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome. FEBS Lett 2007;581:5664-70.
    • (2007) FEBS Lett , vol.581 , pp. 5664-5670
    • Deushi, M.1    Nomura, M.2    Kawakami, A.3    Haraguchi, M.4    Ito, M.5    Okazaki, M.6
  • 24
    • 84455190243 scopus 로고    scopus 로고
    • Ezetimibe monotherapy ameliorates vascular function in patients with hypercholesterolemia through decreasing oxidative stress
    • Kurobe H, Aihara K, Higashida M, Hirata Y, Nishiya M, Matsuoka Y et al. Ezetimibe monotherapy ameliorates vascular function in patients with hypercholesterolemia through decreasing oxidative stress. J Atheroscler Thromb 2011;18:1080-9.
    • (2011) J Atheroscler Thromb , vol.18 , pp. 1080-1089
    • Kurobe, H.1    Aihara, K.2    Higashida, M.3    Hirata, Y.4    Nishiya, M.5    Matsuoka, Y.6
  • 25
    • 29644441199 scopus 로고    scopus 로고
    • Metabolic syndrome - definition and diagnostic criteria in Japan
    • Matsuzawa Y. Metabolic syndrome - definition and diagnostic criteria in Japan. J Jpn Soc Int Med 2005;94:188-203.
    • (2005) J Jpn Soc Int Med , vol.94 , pp. 188-203
    • Matsuzawa, Y.1
  • 26
    • 77952304034 scopus 로고    scopus 로고
    • The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
    • Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009;32:3-107.
    • (2009) Hypertens Res , vol.32 , pp. 3-107
    • Ogihara, T.1    Kikuchi, K.2    Matsuoka, H.3    Fujita, T.4    Higaki, J.5    Horiuchi, M.6
  • 27
    • 65549111017 scopus 로고    scopus 로고
    • Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan
    • Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K et al. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982-92.
    • (2009) Am J Kidney Dis , vol.53 , pp. 982-992
    • Matsuo, S.1    Imai, E.2    Horio, M.3    Yasuda, Y.4    Tomita, K.5    Nitta, K.6
  • 29
    • 77955519012 scopus 로고    scopus 로고
    • NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease
    • Enjoji M, Machida K, Kohjima M, Kato M, Kotoh K, Matsunaga K et al. NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease. Lipids Health Dis 2010;12:9-29.
    • (2010) Lipids Health Dis , vol.12 , pp. 9-29
    • Enjoji, M.1    Machida, K.2    Kohjima, M.3    Kato, M.4    Kotoh, K.5    Matsunaga, K.6
  • 31
    • 77954366025 scopus 로고    scopus 로고
    • Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: an open-label, pilot study
    • Yoneda M, Fujita K, Nozaki Y, Endo H, Takahashi H, Hosono K et al. Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: an open-label, pilot study. Hepatol Res 2010;40:613-21.
    • (2010) Hepatol Res , vol.40 , pp. 613-621
    • Yoneda, M.1    Fujita, K.2    Nozaki, Y.3    Endo, H.4    Takahashi, H.5    Hosono, K.6
  • 33
    • 34547726814 scopus 로고    scopus 로고
    • Effects of diet-induced moderate weight reduction on intrahepatic and intramyocellular triglycerides and glucose metabolism in obese subjects
    • Sato F, Tamura Y, Watada H, Kumashiro N, Igarashi Y, Uchino H et al. Effects of diet-induced moderate weight reduction on intrahepatic and intramyocellular triglycerides and glucose metabolism in obese subjects. J Clin Endocrinol Metab 2007;92:3326-9.
    • (2007) J Clin Endocrinol Metab , vol.92 , pp. 3326-3329
    • Sato, F.1    Tamura, Y.2    Watada, H.3    Kumashiro, N.4    Igarashi, Y.5    Uchino, H.6
  • 34


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.